Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial

著者: Nils Venhoff, Wolfgang Schmidt, Raoul Bergner, Jürgen Rech, L. Unger, Hans‐Peter Tony, Stephanie Finzel, Ioana Andreica, David M. Kofler, Stefan M. Weiner, Peter Lamprecht, Hendrik Schulze‐Koops, Christine App, Effie Pournara, Meryl H. Mendelson, Christian Sieder, M. Maricos, Jens Thiel - The Lancet 2023 被引用: 89